TY - JOUR
T1 - CD11b+CD43hiLy6Closplenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis
AU - Zhang, Shaoying
AU - Wan, Dan
AU - Zhu, Mengchen
AU - Wang, Guihu
AU - Zhang, Xurui
AU - Huang, Na
AU - Zhang, Jian
AU - Zhang, Chongyu
AU - Shang, Qi
AU - Zhang, Chen
AU - Liu, Xi
AU - Liang, Fanfan
AU - Zhang, Chunyan
AU - Kong, Guangyao
AU - Geng, Jing
AU - Yao, Libo
AU - Lu, Shemin
AU - Chen, Yongyan
AU - Li, Zongfang
N1 - Publisher Copyright:
© 2023 John Wiley and Sons Inc.. All rights reserved.
PY - 2023/5
Y1 - 2023/5
N2 - Background and Aims: Monocyte-derived macrophages (MoMFs), a dominant population of hepatic macrophages under inflammation, play a crucial role in liver fibrosis progression. The spleen serves as an extra monocyte reservoir in inflammatory conditions; however, the precise mechanisms of involvement of the spleen in the pathogenesis of liver fibrosis remain unclear. Approach and Results: By splenectomy and splenocyte transfusion, it was observed that splenic CD11b+cells accumulated intrahepatically as Ly6CloMoMFs to exacerbate CCl4-induced liver fibrosis. The splenocyte migration into the fibrotic liver was further directly visualized by spleen-specific photoconversion with KikGR mice and confirmed by CD45.1+/CD45.2+spleen transplantation. Spleen-derived CD11b+cells purified from fibrotic livers were then annotated by single-cell RNA sequencing, and a subtype of CD11b+CD43hiLy6Closplenic monocytes (sM-1s) was identified, which was markedly expanded in both spleens and livers of mice with liver fibrosis. sM-1s exhibited mature feature with high expressions of F4/80, produced much ROS, and manifested preferential migration into livers. Once recruited, sM-1s underwent sequential transformation to sM-2s (highly expressed Mif, Msr1, Clec4d, and Cstb) and then to spleen-derived macrophages (sMϕs) with macrophage features of higher expressions of CX3CR1, F4/80, MHC class II, and CD64 in the fibrotic hepatic milieu. Furthermore, sM-2s and sMϕs were demonstrated capable of activating hepatic stellate cells and thus exacerbating liver fibrosis. Conclusions: CD11b+CD43hiLy6Closplenic monocytes migrate into the liver and shift to macrophages, which account for the exacerbation of liver fibrosis. These findings reveal precise mechanisms of spleen-liver axis in hepatic pathogenesis and shed light on the potential of sM-1 as candidate target for controlling liver diseases.
AB - Background and Aims: Monocyte-derived macrophages (MoMFs), a dominant population of hepatic macrophages under inflammation, play a crucial role in liver fibrosis progression. The spleen serves as an extra monocyte reservoir in inflammatory conditions; however, the precise mechanisms of involvement of the spleen in the pathogenesis of liver fibrosis remain unclear. Approach and Results: By splenectomy and splenocyte transfusion, it was observed that splenic CD11b+cells accumulated intrahepatically as Ly6CloMoMFs to exacerbate CCl4-induced liver fibrosis. The splenocyte migration into the fibrotic liver was further directly visualized by spleen-specific photoconversion with KikGR mice and confirmed by CD45.1+/CD45.2+spleen transplantation. Spleen-derived CD11b+cells purified from fibrotic livers were then annotated by single-cell RNA sequencing, and a subtype of CD11b+CD43hiLy6Closplenic monocytes (sM-1s) was identified, which was markedly expanded in both spleens and livers of mice with liver fibrosis. sM-1s exhibited mature feature with high expressions of F4/80, produced much ROS, and manifested preferential migration into livers. Once recruited, sM-1s underwent sequential transformation to sM-2s (highly expressed Mif, Msr1, Clec4d, and Cstb) and then to spleen-derived macrophages (sMϕs) with macrophage features of higher expressions of CX3CR1, F4/80, MHC class II, and CD64 in the fibrotic hepatic milieu. Furthermore, sM-2s and sMϕs were demonstrated capable of activating hepatic stellate cells and thus exacerbating liver fibrosis. Conclusions: CD11b+CD43hiLy6Closplenic monocytes migrate into the liver and shift to macrophages, which account for the exacerbation of liver fibrosis. These findings reveal precise mechanisms of spleen-liver axis in hepatic pathogenesis and shed light on the potential of sM-1 as candidate target for controlling liver diseases.
UR - https://www.scopus.com/pages/publications/85140094472
U2 - 10.1002/hep.32782
DO - 10.1002/hep.32782
M3 - 文章
C2 - 36098707
AN - SCOPUS:85140094472
SN - 0270-9139
VL - 77
SP - 1612
EP - 1629
JO - Hepatology
JF - Hepatology
IS - 5
ER -